NCT00244582View on ClinicalTrials.gov

Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

October 22, 2005

Study Completion Date

November 3, 2006

Conditions
Type 2 Gaucher Disease
Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00244582 - Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease | Biotech Hunter | Biotech Hunter